Journal of cystic fibrosis : official journal of the European Cystic Fibrosis SocietyHumansPregnancyFemalePharmacovigilanceCystic Fibrosis
CFTR during pregnancy and adverse drug reactions: A pharmacovigilance disproportionality analysis in VigiBase.
Nazanin Abolhassani, Kim Dao, Roberta Noseda, Francesca Bedussi, Alessandro Ceschi, Alice Panchaud, Ursula Winterfeld
Published: 202610.1016/j.jcf.2025.11.007
Abstract
BACKGROUND: Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have transformed the management of cystic fibrosis (CF), but evidence on their safety during pregnancy remains limited and pregnancy-related adverse drug reactions (ADR…
Preview only. Read the full abstract at the source